These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23941729)

  • 21. Antagonistic action of novel 1alpha,25-dihydroxyvitamin D3-26, 23-lactone analogs on differentiation of human leukemia cells (HL-60) induced by 1alpha,25-dihydroxyvitamin D3.
    Miura D; Manabe K; Ozono K; Saito M; Gao Q; Norman AW; Ishizuka S
    J Biol Chem; 1999 Jun; 274(23):16392-9. PubMed ID: 10347199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
    Kim S; Shevde NK; Pike JW
    J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of the 1,25-dihydroxyvitamin D3-24-hydroxylase gene in rat intestine: response to calcium, vitamin D3 and calcitriol administration in vivo.
    Lemay J; Demers C; Hendy GN; Delvin EE; Gascon-Barré M
    J Bone Miner Res; 1995 Aug; 10(8):1148-57. PubMed ID: 8585417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitamin D3 derivatives with adamantane or lactone ring side chains are cell type-selective vitamin D receptor modulators.
    Inaba Y; Yamamoto K; Yoshimoto N; Matsunawa M; Uno S; Yamada S; Makishima M
    Mol Pharmacol; 2007 May; 71(5):1298-311. PubMed ID: 17325131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cholecalciferol supplementation alters calcitriol-responsive monocyte proteins and decreases inflammatory cytokines in ESRD.
    Stubbs JR; Idiculla A; Slusser J; Menard R; Quarles LD
    J Am Soc Nephrol; 2010 Feb; 21(2):353-61. PubMed ID: 20007751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for 1,25-dihydroxyvitamin D3-independent transactivation by the vitamin D receptor: uncoupling the receptor and ligand in keratinocytes.
    Ellison TI; Eckert RL; MacDonald PN
    J Biol Chem; 2007 Apr; 282(15):10953-62. PubMed ID: 17310066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 20-Hydroxyvitamin D3, a product of vitamin D3 hydroxylation by cytochrome P450scc, stimulates keratinocyte differentiation.
    Zbytek B; Janjetovic Z; Tuckey RC; Zmijewski MA; Sweatman TW; Jones E; Nguyen MN; Slominski AT
    J Invest Dermatol; 2008 Sep; 128(9):2271-80. PubMed ID: 18368131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolism of vitamin D: current status.
    DeLuca HF
    Am J Clin Nutr; 1976 Nov; 29(11):1258-70. PubMed ID: 187053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of vitamin D synthesis and catabolism in colorectal mucosa: a new target for cancer prevention.
    Cross HS; Nittke T; Peterlik M
    Anticancer Res; 2009 Sep; 29(9):3705-12. PubMed ID: 19667168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A High-Calcium and Phosphate Rescue Diet and VDR-Expressing Transgenes Normalize Serum Vitamin D Metabolite Profiles and Renal Cyp27b1 and Cyp24a1 Expression in VDR Null Mice.
    Kaufmann M; Lee SM; Pike JW; Jones G
    Endocrinology; 2015 Dec; 156(12):4388-97. PubMed ID: 26441239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances in our understanding of the vitamin D endocrine system.
    De Luca HF
    J Lab Clin Med; 1976 Jan; 87(1):7-26. PubMed ID: 173767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colon-specific regulation of vitamin D hydroxylases--a possible approach for tumor prevention.
    Kállay E; Bises G; Bajna E; Bieglmayer C; Gerdenitsch W; Steffan I; Kato S; Armbrecht HJ; Cross HS
    Carcinogenesis; 2005 Sep; 26(9):1581-9. PubMed ID: 15905206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potent antiproliferative effects of 25-hydroxy-16-ene-23-yne-vitamin D₃ that resists the catalytic activity of both CYP27B1 and CYP24A1.
    Rhieu SY; Annalora AJ; LaPorta E; Welsh J; Itoh T; Yamamoto K; Sakaki T; Chen TC; Uskokovic MR; Reddy GS
    J Cell Biochem; 2014 Aug; 115(8):1392-402. PubMed ID: 24535953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamin D and lung cancer.
    Ramnath N; Kim S; Christensen PJ
    Expert Rev Respir Med; 2011 Jun; 5(3):305-9. PubMed ID: 21702651
    [No Abstract]   [Full Text] [Related]  

  • 35. Dietary vitamin D₃ and 1,25-dihydroxyvitamin D₃ (calcitriol) exhibit equivalent anticancer activity in mouse xenograft models of breast and prostate cancer.
    Swami S; Krishnan AV; Wang JY; Jensen K; Horst R; Albertelli MA; Feldman D
    Endocrinology; 2012 Jun; 153(6):2576-87. PubMed ID: 22454149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum vitamin D metabolites in colorectal cancer patients receiving cholecalciferol supplementation: correlation with polymorphisms in the vitamin D genes.
    Muindi JR; Adjei AA; Wu ZR; Olson I; Huang H; Groman A; Tian L; Singh PK; Sucheston LE; Johnson CS; Trump DL; Fakih MG
    Horm Cancer; 2013 Aug; 4(4):242-50. PubMed ID: 23456391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of 25-hydroxyvitamin D3 1alpha-hydroxylase, 1,25-dihydroxyvitamin D3 24-hydroxylase and vitamin D receptor gene expression by 8-bromo cyclic AMP in cultured human syncytiotrophoblast cells.
    Avila E; Díaz L; Halhali A; Larrea F
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):115-9. PubMed ID: 15225757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 25-hydroxy-vitamin d metabolism in human colon cancer cells during tumor progression.
    Bareis P; Bises G; Bischof MG; Cross HS; Peterlik M
    Biochem Biophys Res Commun; 2001 Jul; 285(4):1012-7. PubMed ID: 11467853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiproliferative responses to two human colon cancer cell lines to vitamin D3 are differently modified by 9-cis-retinoic acid.
    Kane KF; Langman MJ; Williams GR
    Cancer Res; 1996 Feb; 56(3):623-32. PubMed ID: 8564982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 24-Hydroxylase in cancer: impact on vitamin D-based anticancer therapeutics.
    Luo W; Hershberger PA; Trump DL; Johnson CS
    J Steroid Biochem Mol Biol; 2013 Jul; 136():252-7. PubMed ID: 23059474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.